Essex Bio-Technology Limited (HKG:1061)
2.720
-0.120 (-4.23%)
Jul 13, 2026, 11:45 AM HKT
Essex Bio-Technology Market Cap
Essex Bio-Technology has a market cap or net worth of 1.61 billion as of July 10, 2026. Its market cap has decreased by -39.57% in one year.
Market Cap
1.61B
Enterprise Value
1.17B
Revenue
1.81B
Ranking
n/a
PE Ratio
5.06
Stock Price
2.72
Market Cap Chart
Since June 27, 2001, Essex Bio-Technology's market cap has increased from 507.69M to 1.61B, an increase of 217.18%. That is a compound annual growth rate of 4.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.61B | -24.67% |
| Dec 31, 2025 | 2.14B | 28.20% |
| Dec 31, 2024 | 1.67B | 17.98% |
| Dec 29, 2023 | 1.41B | -41.13% |
| Dec 30, 2022 | 2.40B | -15.72% |
| Dec 31, 2021 | 2.85B | 15.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edding Genor Group Holdings | 3.92B |
| Hua Medicine (Shanghai) | 2.66B |
| Chia Tai Enterprises International | 2.41B |
| Golden Throat Holdings Group Company | 2.29B |
| VISEN Pharmaceuticals | 2.21B |
| Jacobson Pharma Corporation | 2.18B |
| JBM (Healthcare) | 1.63B |
| Dawnrays Pharmaceutical (Holdings) | 1.51B |